Physician
Cardiac Associates, P.C.
Cardiac Associates, P.C. was paid $1.74M by Medicaid between Jan 2018 and Jan 2022, across 44 billing codes. Its largest line is 93306, Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete — 30% of everything it billed.
33Billing provider infoCARDIAC ASSOCIATES, P.C.
ROCKVILLE, MD 20850
ROCKVILLE, MD 20850
33aNPI1255473179assigned 02/14/2007
33bProvider typeCardiovascular Disease Physician
28Total paid$1.74M
24GClaims87,282
24DCodes billed44
24AFirst – last monthJan 2018 – Jan 2022
Compared with peers
Next to other Cardiovascular Disease Physician providers in Maryland
Rank by total paid#3 of 78
Median peer was paid$37K
This provider vs. median47×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,940 | $738K | |
| 2019 | 20,928 | $455K | |
| 2020 | 18,784 | $253K | |
| 2021 | 21,419 | $270K | |
| 2022 | 1,211 | $24K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 30% | 6,417 | 6,134 | $526K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 7,992 | 7,485 | $405K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 12% | 1,039 | 964 | $205K |
| 93000 | 8.0% | 12,269 | 11,272 | $139K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.1% | 2,257 | 2,074 | $89K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.6% | 1,516 | 716 | $80K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.4% | 965 | 919 | $76K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 2.8% | 6,501 | 6,232 | $50K |
| 99222 | Initial hospital care, per day, moderate complexity | 2.5% | 627 | 596 | $44K |
| 93015 | 2.5% | 1,088 | 1,012 | $44K | |
| 93296 | <1% | 1,016 | 978 | $14K | |
| 93280 | <1% | 383 | 371 | $12K |
32 more codes
| G8783 | Normal blood pressure reading documented, follow-up not required | <1% | 4,328 | $11K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 526 | $8K |
| G1007 | Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program | <1% | 31 | $6K |
| 93294 | <1% | 592 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 53 | $4K |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | <1% | 1,332 | $4K |
| 93297 | <1% | 598 | $3K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 108 | $3K |
| 93970 | <1% | 17 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 255 | $3K |
| 93880 | <1% | 15 | $2K | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 5,955 | $1K |
| 93299 | <1% | 117 | $1K | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 2,720 | $1K |
| 93224 | <1% | 12 | $1K | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 3,383 | $974.36 |
| 99221 | <1% | 26 | $919.64 | |
| 0296T | <1% | 97 | $832.82 | |
| 1123F | <1% | 4,526 | $623.42 | |
| 0298T | <1% | 147 | $579.46 | |
| 4086F | <1% | 3,595 | $403.19 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 456 | $249.48 |
| 1036F | <1% | 5,972 | $188.65 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | <1% | 855 | $126.87 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 5,382 | $44.12 |
| G8598 | Aspirin or another antiplatelet therapy used | <1% | 2,449 | $11.12 |
| 93248 | <1% | 12 | $6.04 | |
| G8599 | Aspirin or another antiplatelet therapy not used, reason not given | <1% | 242 | $0.30 |
| G9724 | Patients who had documentation of use of anticoagulant medications overlapping the measurement year | 0% | 79 | $0.00 |
| 4004F | 0% | 260 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 67 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 1,005 | $-5558.35 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRYCE, SHARON (CHIEF OPERATING OFFICER)